China becomes key strategic market for CSL
Australian biopharmaceutical company CSL has designated China as one of its most important strategic markets worldwide, a milestone highlighted by a significant expansion of both its workforce and investment in the country, said a senior executive. Since 1986, CSL — a century-old firm — has supplied human albumin to Chinese patients, with a large proportion…









